Results 11 to 20 of about 3,342 (167)

Anti HCV seropozitif kişilerde moleküler HCV RNA test sonuçlarının değerlendirilmesi

open access: yesTurkish Journal of Family Practice, 2013
Amaç: Bu araştırmada, Anti HCV pozitif kişilerin HCV RNA viral yük miktarları incelenerek, akut enfeksiyon sonrası iyileşme, kronikleşme, hastaların tedavi yanıtları ve bunların cinsiyet ile iliflkisinin değerlendirilmesi amaçlanmıştır.
Cem Çelik   +4 more
doaj   +1 more source

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

open access: yesHepatology, EarlyView., 2022
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai   +29 more
wiley   +1 more source

Multicenter evaluation of the new Alinity s anti-HCV II assay for routine hepatitis C virus blood screening

open access: yesJournal of Clinical Virology Plus, 2023
Background: Anti-HCV immunoassays remain the primary serologic test for HCV screening among blood donors. Since 1990s, Anti-HCV assays have evolved and those currently available detect infection earlier and have improved sensitivity and specificity ...
Wai-Chiu Tsoi   +6 more
doaj   +1 more source

Identification of novel neutralizing determinants for protection against HCV

open access: yesHepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua   +12 more
wiley   +1 more source

Evaluation of the automated fluorescent immunoassay system anti-hepatitis C virus assay for the detection of hepatitis C virus infection

open access: yesGlobal Journal of Transfusion Medicine, 2019
Introduction: Hepatitis C has emerged as a fatal epidemic in the country in the past two decades. One of the major risk factors remains unsafe blood transfusions.
Usman Waheed   +8 more
doaj   +1 more source

Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection. [PDF]

open access: yesPLoS ONE, 2014
The aim of this study is to explore the prevalence of hepatitis C virus (HCV) infection among injection drug users (IDUs) with and without human immunodeficiency virus (HIV) infection in southern Taiwan.
Meng-Hsuan Hsieh   +13 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients [PDF]

open access: yesTürk Biyokimya Dergisi, 2007
Hepatitis C Virus (HCV) infection is frequently diagnosed by detection of antibodyagainst the HCV (Anti-HCV). The seropositivity of anti-HCV could reflect chronicinfectious status and/or previous infection.
Tuğrul Himmetoğlu   +5 more
doaj  

A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detection

open access: yesVirology Journal, 2021
Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of recombinant antigens to detect antibody response. Antibody responses to individual antigenic regions (core, NS3/4 and NS5) used in assays have not been ...
Xinyi Jiang   +6 more
doaj   +1 more source

Analysis of reactive HCV results detected by current blood screening strategy

open access: yesZhongguo shuxue zazhi, 2022
Objective To assess the status of HCV infection by analyzing the results of anti-HCV reactive blood samples detected by the current blood testing strategy, and discuss the viability of classified management of reactive blood donors.
ZhengMin LIU   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy